Bosnia and Herzegovina vs Czechia: The number of people with susceptibility test result for rifampicin
Bosnia and Herzegovina
255
in 2021
Czechia
239
in 2021
Bosnia and Herzegovina rank
89th
Czechia rank
90th
The number of people with susceptibility test result for rifampicin over time
- Bosnia and Herzegovina
- Czechia
How they compare
Bosnia and Herzegovina currently reports 255 against 239 in Czechia, a difference of 16.
That makes Bosnia and Herzegovina's figure about 1.1 times Czechia's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 89th and Czechia ranks 90th of 155 countries.
Bosnia and Herzegovina has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Czechia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 362 | 294 | 68 | Bosnia and Herzegovina |
| 2020s | 231.5 | 231 | 0.5 | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bosnia and Herzegovina or Czechia?
- Bosnia and Herzegovina, at 255 against 239 in Czechia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bosnia and Herzegovina and Czechia?
- 16, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Czechia?
- 5 years are reported by both, from 2017 to 2021.
- How do Bosnia and Herzegovina and Czechia rank globally for the number of people with susceptibility test result for rifampicin?
- Bosnia and Herzegovina ranks 89th and Czechia ranks 90th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.